MEDIS IN THE NEWS
May 5th, 2007
MEDIS
TECHNOLOGIES SCHEDULES FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE
CALL
New York, NY – May 2, 2007 - Medis Technologies Ltd. (NASDAQ:MDTL)
(“Medis”) announced today that it will issue its financial
results for the first quarter ended March 31, 2007 on Wednesday, May
9, 2007. Management will also conduct a conference call that morning
at 11:00 AM Eastern Time to discuss these results and the current status
of its business operations.
Interested parties may participate in the call by dialing 866-820-1713
(Domestic) or 706-643-3137 (International) approximately 10 minutes
before the call is scheduled to begin and ask to be connected to the
Medis conference call or conference code 7926184. A recorded replay
of the call will be available until 12:00 a.m. Eastern Time on May 16,
2007. Listeners may dial 800-642-1687 (Domestic) or 706-645-9291 (International)
and use the code 7926184 for the replay.
The call will also be simultaneously broadcast over the Internet. To
listen to the live webcast, please click on this conference call link
The conference call will be archived and accessible for approximately
30 days if you are unable to listen to the live call.
Medis Technologies’ primary focus is on direct liquid fuel cell
technology. Its business strategy is to sell its products to end users
through retail outlets, service providers and to the military and other
markets. Medis has also developed the CellScan with many potential applications
relating to disease diagnostics and chemo sensitivity. Additionally,
Medis’ product pipeline
includes other technologies, in varying stages of development.
This press release
may contain forward-looking statements, which are made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform Act
of 1995. In some cases you can identify those so-called “forward-looking
statements” by words such as “may,” “will,”
“should,” “expects,” “plans,” “targets,”
“believes,” “anticipates,” “estimates,”
“predicts,” “potential,” or “continue”
or the negative of those words and other comparable words. These forward-looking
statements are subject to risks and uncertainties, product tests, commercialization
risks, availability of financing and results of financing efforts that
could cause actual results to differ materially from historical results
or those anticipated. Further information regarding these and other
risks is described from time to time in the Company's filings with the
SEC. We assume no obligation to update or alter our forward-looking
statements made in this release or in any periodic report filed by us
under the Securities Exchange Act of 1934 or any other document, whether
as a result of new information, future events or otherwise, except as
otherwise required by applicable federal securities laws. |
